Zura Bio Limited
ZURANASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $542.72M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.15$7.44
- Volume (live)
- -
- Avg. volume (3M)
- 3.03M
Zura Bio (ZURA) Stock Price & Financial Analysis
Zura Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.86 - $4.35 |
|---|---|
| 52-Week High | $7.44 |
| 52-Week Low | $3.15 |
| Open | $4.30 |
| Volume (last close) | 4.90M |
| Average Volume (3M) | 3.03M |
| 50-Day MA | $5.09 |
|---|---|
| 200-Day MA | $5.31 |
| 1-Year Change | +33.33% |
| Market Cap | 542.72M |
|---|---|
| Shares Outstanding | 126.80M |
| Price to Book (P/B) | 2.75 |
| EV/EBITDA | -3.75 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Zura Bio at a Glance
As of the Oct 16, 2026 close, Zura Bio (ZURA) has a market capitalization of $542.72M.
As of its latest reported balance sheet, it holds $205.13M in cash and securities against $0.00 of debt, a net cash position of $205.13M.
Zura Bio does not currently pay a dividend.
The share price is up 33.3% over the past year. At $3.88 (the Oct 16, 2026 close) it sits within its 52-week range of $3.15 to $7.44, below its 200-day moving average of $5.31.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $19.75, 409.0% above the Oct 16, 2026 close.
Frequently Asked Questions About Zura Bio
What is the current stock price for ZURA?
As of the Oct 16, 2026 close, ZURA stock trades at $3.88. The 52-week range is $3.15–$7.44, with a day range of $3.86–$4.35.
What is the P/E ratio for ZURA?
The P/E ratio (Price-to-Earnings) for ZURA is shown in the Key Statistics section. This valuation metric helps compare Zura Bio Limited to industry peers.
Does ZURA pay dividends?
Zura Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ZURA?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for ZURA is Buy. The average 12-month price target is $19.75, a 409.0% upside from the Oct 16, 2026 close of $3.88.
What is the market cap of ZURA?
As of the Oct 16, 2026 close, Zura Bio's market capitalization is $492.0M, classifying it as a small-cap company. Zura Bio operates in the Healthcare sector within the Biotechnology industry.